Cloud DX Announces Consortium to Advance Affordable Hospital-Level Care at Home

News in Summary

  • Led by Medtronic (NYSE:MDT), in partnership with Excelar Technologies, Providence Health Care Ventures, Simon Fraser University, 3D Bridge Solutions and StarFish Medical, Cloud DX will develop and commercialize a Continuous Connected Patient Care (CCPC) digital platform to improve quality of at-home care for discharged patients, saving in-hospital resources for acute patient cases.
  • The project has a total investment of $12.8M, with $5.2M co-invested through the Digital Supercluster based in Vancouver, BC. It is expected to launch in 2024.
  • As milestones are met, Cloud DX will receive up to $560,000 CAD over the project span to support the integration of a new Medtronic continuous vital sign monitoring device and a connected medication dispenser to the Connected Health software platform.

Cloud DX (TSXV:CDX)(OTC:CDXFF), a leading digital health platform, today announced $5.2 million CAD of co-investment from the Digital Supercluster, through Innovation, Science and Economic Development Canada to create the Continuous Connected Patient Care (CCPC) digital platform. Continuous remote monitoring of recently discharged patients is expected to improve patient outcomes and free up badly needed hospital resources

Cloud DX Inc., Tuesday, November 8, 2022, Press release picture

This novel remote patient monitoring system project will be led by Medtronic and include expertise and technology from a consortium of partners, including Excelar Technologies, Providence Health Care's St. Paul's Hospital, Providence Health Care Ventures, Simon Fraser University, 3D Bridge Solutions Inc, and StarFish Medical (as a Medtronic sub-contractor).

Each consortium member offers a unique and vital component to create the seamless end-to-end monitoring system for clinicians and patients at the hospital as a solution to the challenge of providing affordable, easy-to-use, hospital-grade care at home.

"Hospital resources should be focused on patients with the most urgent and severe illnesses, but many people hospitalized for significant health issues remain there for basic supervision and monitoring while they heal," says Rick Sethi, CCPC Project Leader and Director of Open Innovation at Medtronic. "CCPC is about improving patient outcomes by providing hospital-level monitoring at home for less acute patients -- sparing them from unnecessarily long hospital stays and subsequently, reducing wait times and freeing up resources for patients who need in-hospital care."

Medtronic will provide a new multi-parameter untethered sensor device, based on proven clinical-grade medical sensor technologies.

3D Bridge Solutions will further enhance its AlthaRX (Altha) medication dispensing, tracking, and adherence monitoring device and software. The Cloud DX and 3D Bridge solutions will be integrated into the overall CCPC platform via the Excelar Careflow Broker. Excelar will enhance its clinical data normalization module to include remote patient monitoring and medication adherence tracking data as well as significantly enhancing its patient timeline care flow data visualization module.

Providence Health Care Ventures (PHCV) will provide patient and clinical needs assessment, workflow, and validation, co-design and co-development of the end-solution, as well as data governance and integration. The Consortium will work with St. Paul's Hospital clinicians on the requirements definition and process design.

Simon Fraser University (SFU) will elicit users' needs to inform the development of the sensor, clinical workflows for an untethered blood pressure monitor or trend device, clinical decision support model, and user interfaces for clinicians, and patients and their families.

Cloud DX will provide the patented, ISO certified ‘backbone' for the CCPC project including an enhanced patient-facing Connected Health kit and mobile application, data collection and secure cloud-based storage, smart clinician notification system, as well as patient engagement tools including surveys, text messaging and video telehealth capabilities. The Cloud DX Clinician Portal will be used by care teams to monitor up to thousands of patients safely, reducing workloads and improving efficiency.

The Digital Supercluster is a co-investment partner, providing $5.2 million in funding to accelerate made-in-Canada healthcare innovation and improve outcomes from health services. The CCPC platform is expected to be completed and approved by regulators in 2024, at which time, Medtronic intends to market the platform to healthcare providers in over 125 countries.

"Hospital care can cost up to $2,000 per patient per day, which creates a huge cost burden for our healthcare system. Using an advanced home monitoring solution, such as CCPC, can shift a large proportion of that cost to a more affordable "hospital at home" model," says Robert Kaul, CEO of Cloud DX. "Hospitals can safely send less acutely ill patients home without compromising quality of care, freeing up urgently needed hospital resources including beds, equipment, and staff."

The Continuous Connected Patient Care digital project will initially focus on adults with congestive heart failure and chronic obstructive pulmonary disease, with attention on internal medicine and geriatrics. Under the funding agreement, patients, families, clinicians, and industry partners will collaborate to build, test, evaluate and demonstrate the applicability of the CCPC platform, as well as gather critical data related to patient healthcare outcomes that will underpin broader commercial deployment in the future.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cloud DX Inc., Tuesday, November 8, 2022, Press release picture

About Cloud DX
Accelerating digital healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health™ remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, 2022 Top Innovator by Canadian Business, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." Cloud DX is an exclusive partner to Medtronic Canada, Teladoc Health Canada, and Equitable Life of Canada. For more Visit www.CloudDX.com and follow @CloudDX on Twitter and LinkedIn.

Cloud DX will present at the Emerging Growth Conference November 9, 2022 at 11:25 AM Eastern Time. CEO Robert Kaul will present on recent news and host open floor for questions. If interested, register here.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies address 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow @MedtronicCA on Twitter and LinkedIn.

Additional partners include 3D Bridge Solutions Inc., Excelar Technologies, Providence Health Care Ventures, Simon Fraser University, and StarFish Medical (Medtronic contractor).

About 3D Bridge Solutions

3D Bridge Solutions has developed a secure cloud-based prescription management system which supports patient adherence for all types of medications through the use of connected tamper-resistant devices. It is designed for people suffering from chronic diseases including older adults who could benefit from better medication adherence and vital monitoring.

About Excelar Technologies

Excelar's CareFlow platform is a privacy-by-design solution for clinical data integration, normalization, and data visualization. The platform consists of the Careflow Broker for intelligent data processing, routing and data normalization, Careflow Insight dashboards for patterns of practice clinical quality improvement, and Careflow Timeline for the intuitive visualization of clinically relevant data using explainable AI. www.excelar.ca

About Providence Health Care Ventures

Providence Health Care Ventures nurtures and accelerates the commercialization of health care solutions while reinvesting resources into social justice causes and continued innovation growth at Providence Health Care (PHC) and the creation of a learning-health system. Ventures offers health system expertise, access to the PHC ecosystem, and the capacity to navigate the health care landscape. We collaborate with like-minded stakeholders to bring leading-edge health care solutions to the market for the benefit of all.

About Simon Fraser University

As Canada's engaged university, Simon Fraser University works with communities, organizations and partners to create, share and embrace knowledge that improves life and generates real change. We deliver a world-class education with lifelong value that shapes change-makers, visionaries and problem-solvers. We connect research and innovation to entrepreneurship and industry to deliver sustainable, relevant solutions to today's problems. With campuses in British Columbia's three largest cities - Vancouver, Burnaby and Surrey - SFU has eight faculties that deliver 193 undergraduate degree programs and 127 graduate degree programs to more than 35,000 students. The university now boasts more than 160,000 alumni residing in 143 countries.

About Starfish Medical

Empowering Medtech Innovation ® StarFish Medical™ is an award winning, full service Medical Device Design company offering design, development, and NPI manufacturing services based in Toronto and Victoria BC. Our Pathfinder™ process reduces wasted effort and increases success for medical device product definition, technical engineering, and product development. Prototype and volume production are delivered within an ISO 13485 certified Quality Management System, manufacturing and clean room facilities. www.starfishmedical.com

About Digital Supercluster

Ahead of the curve starts here. The Digital Supercluster is building a better Canada by growing Canadian businesses, creating a digitally skilled workforce and positively impacting lives across our country. We accelerate the development and adoption of digital technologies that keep Canadians healthy, address climate change and drive economic productivity. Through a powerful combination of co-investment, cross-sector collaboration, IP creation and digital talent development, we unlock the potential of Canadians to lead and succeed in the Digital world. For more information, visit: https://www.digitalsupercluster.ca/.

For media inquiries, please contact:

Cloud DXMedtronicProvidence Health Care Ventures

Janine Scott

Marketing Lead

janine.scott@CloudDX.com

888-543-0944

Tammy Hudson

Public Relations

Tammy.m.hudson@medtronic.com

Ann Gibbon

Media Relations

Agibbon@providencehealth.bc.ca

778-999-0064

For investor inquiries, please contact:

Cloud DXMedtronic

Canada:

Jay Bedard

647-881-8418

investors@CloudDX.com

US:

Gary Zwetchkenbaum
718-224-3123 or
516-455-7662
ir@CloudDX.com

Ryan Weispfenning

Investor Relations

763-505-4626

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/724547/Cloud-DX-Announces-Consortium-to-Advance-Affordable-Hospital-Level-Care-at-Home

News Provided by ACCESSWIRE via QuoteMedia

MDT
The Conversation (0)
Pine Cliff Energy Ltd. Announces First Quarter 2024 Results and Information Regarding the Annual Meeting of Shareholders

Pine Cliff Energy Ltd. Announces First Quarter 2024 Results and Information Regarding the Annual Meeting of Shareholders

Pine Cliff Energy Ltd. (TSX: PNE) ("Pine Cliff" or the "Company") announces its first quarter 2024 financial and operating results, an operational update and information regarding the annual meeting of shareholders.

First Quarter 2024 Results

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Canadian Natural Resources Limited Announces 2024 First Quarter Results

Canadian Natural's (TSX: CNQ) (NYSE: CNQ) President, Scott Stauth, commented on the Company's first quarter results, "Canadian Natural is a world class company and during our 35 years of operations, we've delivered significant value, including recently reaching a position where, commencing in 2024, we are returning 100% of our free cash flow to our shareholders. Crude oil price forecasts have strengthened for the remainder of 2024, including improvements in West Texas Intermediate ("WTI"), Western Canadian Select ("WCS") and Synthetic Crude Oil ("SCO") pricing over those prices experienced in the first quarter of 2024, driving significant targeted free cash flow generation going forward.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Pine Cliff Energy Ltd. Announces Appointment of Officers, Declares Monthly Dividend for May 31, 2024 and First Quarter 2024 Webcast Details

Pine Cliff Energy Ltd. Announces Appointment of Officers, Declares Monthly Dividend for May 31, 2024 and First Quarter 2024 Webcast Details

Pine Cliff Energy Ltd. (TSX: PNE) (OTCQX: PIFYF) ("Pine Cliff" or the "Company") is pleased to announce the appointments of Mr. Daniel Keenan P. Eng to the position of Vice President Exploitation and Mr. Austin Nieuwdorp CA, CPA to the position of Vice President Finance and Controller both effective May 1, 2024.

Mr. Keenan became part of Pine Cliff in 2016. He holds a Bachelor of Mechanical Engineering Degree from the University of Victoria obtained in 2001. Throughout his 20-year career, he has taken on increasingly challenging roles in exploitation, production operations and facilities engineering, culminating in his most recent position as Pine Cliff's Manager of Exploitation. Notably, Mr. Keenan has played a pivotal role in identifying and expanding Pine Cliff's asset portfolio and drilling opportunities, showcasing his leadership and strategic vision.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ATCO Ltd. to Share Strategic Update at Annual General Meeting on May 15, 2024

ATCO Ltd. to Share Strategic Update at Annual General Meeting on May 15, 2024

ATCO Ltd. (TSX: ACO.X) (TSX: ACO.Y)

2024 ATCO AGM (CNW Group/ATCO Ltd.)

ATCO Ltd. (ATCO) will hold its 57th Annual General Meeting of share owners at 10 a.m. MDT on Wednesday , May 15, 2024. In addition to the formal business of the meeting, attendees will hear management's view of ATCO's full year 2023 and first quarter 2024 operational and financial performance.

At this year's meeting, members of the ATCO executive leadership team will also outline growth strategies and goals for ATCO Structures, ATCO EnPower and ATCO Energy Systems.

Attendees will hear from:

  • Nancy Southern , Chair & Chief Executive Officer
  • Katie Patrick , Executive Vice President, Chief Financial & Investment Officer
  • Adam Beattie , President, ATCO Structures
  • Bob Myles , Chief Operating Officer, ATCO EnPower
  • Wayne Stensby , Chief Operating Officer, ATCO Energy Systems

Share owners and interested parties can view the meeting virtually using Microsoft Teams via this link using a web browser (Chrome, Safari, Edge or Firefox) on a smartphone, tablet or computer. Using Internet Explorer is not recommended as it is no longer supported and may not function properly.

Attendees who are share owners or proxyholders wishing to vote their shares should review the information contained in the ATCO Management Proxy Circular dated March 11, 2024 , beginning on page one.

As a global enterprise ATCO Ltd. and its subsidiary and affiliate companies have approximately 20,000 employees and assets of $25 billion . ATCO is committed to future prosperity by working to meet the world's essential energy, housing, security and transportation challenges. ATCO Structures designs, builds and delivers products to service the essential need for housing and shelter around the globe. ATCO Frontec provides operational support services to government, defence and commercial clients. ATCO Energy Systems delivers essential energy for an evolving world through its electricity and natural gas transmission and distribution, and international operations. ATCO EnPower creates sustainable energy solutions in the areas of renewables, energy storage, industrial water and clean fuels. ATCO Australia develops, builds, owns and operates energy and infrastructure assets. ATCOenergy and Rümi provide retail electricity and natural gas services, home maintenance services and professional home advice that bring exceptional comfort, peace of mind and freedom to homeowners and customers. ATCO also has investments in ports and transportation logistics, the processing and marketing of fly ash, retail food services and commercial real estate. More information can be found at www.ATCO.com .

Investor & Analyst Inquiries:  
Colin Jackson
Senior Vice President, Finance, Treasury & Sustainability
Colin.Jackson@atco.com
(403) 808 2636

Media Inquiries:
Kurt Kadatz
Director, Corporate Communications
Kurt.Kadatz@atco.com
(587) 228 4571

SOURCE ATCO Ltd.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/29/c6613.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

PrairieSky Announces First Quarter 2024 Results, Record Oil Royalty Production

-

PrairieSky Royalty Ltd. ("PrairieSky" or the "Company") (TSX: PSK) is pleased to announce its first quarter ("Q1 2024") operating and financial results for the three-month period ended March 31, 2024.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025 .

Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT ( 10:00 a.m. CDT ). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, to answer questions about the company.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Medtronic announces intent to separate Diabetes business

Medtronic announces intent to separate Diabetes business

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies

Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

  • FDA Breakthrough Device Designation Awarded to AVIM Therapy
  • FDA IDE Approved for Virtue SAB U.S. Pivotal Trial for Launch

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the first quarter ended March 31, 2025, and provided a business update highlighting continued regulatory momentum, disciplined operational execution, and a strengthening clinical development pipeline.

Q1 2025 Highlights:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

Medtronic to announce financial results for its fourth quarter and full fiscal year 2025

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025 . A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https:news.medtronic.com . The news release will include summary financial information for the company's fourth quarter and full fiscal year 2025, which ended on Friday, April 25, 2025 .

Medtronic will host a video webcast at 7:00 a.m. CDT on May 21, 2025 , to discuss results for its fourth quarter and full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women

Star Jones , award winning television personality & women's heart health advocate,   helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign

A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S. many women are still unaware of the risk and the importance of heart health.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×